SA PRO
Free Account
Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
LOADING
|||
Switch Symbol:
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 69% recommend buying.

Consensus Rating
Buy
16 analysts·Moderate coverage
69%
Rating Distribution
Strong Buy
00%
Buy
1169%
Hold
425%
Sell
16%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 27% higher.

Bear Case
$230.00
+19%
Consensus
$245.33
+27%
Bull Case
$275.00
+42%
Price Range16 analysts
Low
Consensus
High
$230.00
$275.00
Current Target
Current Price
$193.28
Upside to Target
$52.05

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Dec 10, 2025Stifel Nicolaus
Ligand price target raised to $230 from $220 at Stifel
Target:$230.00
+23.8%from $185.83
Dec 10, 2025Oppenheimer
Oppenheimer Reiterates Outperform Rating on Ligand Pharma (LGND)
Target:$275.00
+48.0%from $185.83
Nov 6, 2025Stifel Nicolaus
Ligand Pharma (LGND) PT Raised to $220 at Stifel
Target:$220.00
+5.7%from $208.22
Nov 6, 2025H.C. Wainwright
Ligand price target raised to $231 from $206 at H.C. Wainwright
Target:$231.00
+13.0%from $204.50
Nov 3, 2025Oppenheimer
Ligand price target raised to $250 from $190 at Oppenheimer
Target:$250.00
+29.6%from $192.97
Sep 3, 2025Oppenheimer
Ligand price target raised to $190 from $167 at Oppenheimer
Target:$190.00
+14.6%from $165.76
Aug 28, 2025H.C. Wainwright
Ligand price target raised to $206 from $157 at H.C. Wainwright
Target:$206.00
+29.6%from $158.93
Feb 28, 2025UBS
Ligand price target raised to $155 from $143 at RBC Capital
Target:$155.00
+26.8%from $122.23
Oct 21, 2024H.C. Wainwright
Ligand Pharma (LGND) PT Raised to $157 at H.C. Wainwright
Target:$157.00
+45.0%from $108.31
Oct 2, 2024Oppenheimer
Ligand initiated with an Outperform at Oppenheimer
Target:$135.00
+35.1%from $99.95
Jul 30, 2024RBC Capital
RBC Capital Starts Ligand Pharma (LGND) at Outperform
Target:$130.00
+19.5%from $108.75
Jul 9, 2024Craig-Hallum
Ligand price target raised to $140 from $135 at Craig-Hallum
Target:$140.00
+61.1%from $86.88
Jun 28, 2024H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on Ligand Pharma (LGND)
Target:$144.00
+74.9%from $82.33
Dec 23, 2022Roth Capital
Roth Capital Maintains Buy on Ligand Pharmaceuticals, Raises Price Target to $90
Target:$90.00
+33.7%from $67.32

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance